Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene

Virology

Volumn 385, Issue 2, 2009, Pages 455-463

  Low, Audrey ^a   Okeoma, Chioma M ^b   Lovsin, Nika ^c,f   de las Heras, Marcelo ^d   Taylor, Thomas H ^e   Peterlin, B Matija ^c   Ross, Susan R ^b   Fan, Hung ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

APOBEC3; Bone marrow derived dendritic cell; Dendritic cell; Leukemia; Lymphoma; M MuLV: murine APOBEC3; Moloney; Moloney murine leukemia virus; Murine APOBEC3; Murine leukemia virus; Pathogenesis

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; ENHANCED GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; GENE INACTIVATION; GENOTYPE; INFECTION RESISTANCE; KIDNEY TUMOR; KNOCKOUT MOUSE; LEUKEMIA; LEUKEMOGENESIS; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; SPLEEN; T CELL LYMPHOMA; VIRION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; CYTIDINE DEAMINASE; DENDRITIC CELLS; FIBROBLASTS; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY NEOPLASMS; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLONEY MURINE LEUKEMIA VIRUS; TIME FACTORS; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; MUS; SCYPHOZOA;

EID: 60749085330     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.11.051     Document Type: Article

References (50)

1. Abudu A., Takaori-Kondo A., Izumi T., Shirakawa K., Kobayashi M., Sasada A., Fukunaga K., and Uchiyama T. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr. Biol. 16 15 (2006) 1565-1570
2. Belli B., and Fan H. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation. J. Virol. 68 11 (1994) 6883-6889
3. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., and Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14 15 (2004) 1392-1396
4. Bishop K.N., Holmes R.K., and Malim M.H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 80 17 (2006) 8450-8458
5. Bogerd H.P., Wiegand H.L., Hulme A.E., Garcia-Perez J.L., O, Shea K.S., Moran J.V., and Cullen B.R. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. U. S. A. 103 23 (2006) 8780-8785
6. Brightman B.K., Chandy K.G., Spencer R.H., Gupta S., Pattengale P.K., and Fan H. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus. J. Immunol. 141 8 (1988) 2844-2854
7. Brightman B.K., Davis B.R., and Fan H. Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection. J. Virol. 64 9 (1990) 4582-4584
8. Brightman B.K., Rein A., Trepp D.J., and Fan H. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo. Proc. Natl. Acad. Sci. U. S. A. 88 6 (1991) 2264-2268
9. Browne E.P., and Littman D.R. Species-specific restriction of apobec3-mediated hypermutation. J. Virol. 82 3 (2008) 1305-1313
10. Bundy L.M., Ru M., Zheng B.F., Cheng L., Pattengale P.K., Portis J.L., and Fan H. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China. Virology 212 2 (1995) 367-382
11. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., and Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435 7038 (2005) 108-114
12. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., and Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22 2 (2005) 367-377
13. Courreges M.C., Burzyn D., Nepomnaschy I., Piazzon I., and Ross S.R. Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J. Virol. 81 8 (2007) 3769-3777
14. Cullen B.R. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80 3 (2006) 1067-1076
15. Dang Y., Wang X., Esselman W.J., and Zheng Y.H. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 80 21 (2006) 10522-10533
16. Davis B., Linney E., and Fan H. Suppression of leukaemia virus pathogenicity by polyoma virus enhancers. Nature 314 6011 (1985) 550-553
17. Davis B.R., Brightman B.K., Chandy K.G., and Fan H. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis. Proc. Natl. Acad. Sci. U. S. A. 84 14 (1987) 4875-4879
18. Doehle B.P., Schafer A., and Cullen B.R. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology 339 2 (2005) 281-288
19. Doehle B.P., Schafer A., Wiegand H.L., Bogerd H.P., and Cullen B.R. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 79 13 (2005) 8201-8207
20. Hanecak R., Pattengale P.K., and Fan H. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties. J.Virol. 62 7 (1988) 2427-2436
21. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., and Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 113 6 (2003) 803-809
22. Holmes R.K., Malim M.H., and Bishop K.N. APOBEC-mediated viral restriction: not simply editing?. Trends Biochem. Sci. 32 3 (2007) 118-128
23. Kobayashi M., Takaori-Kondo A., Shindo K., Abudu A., Fukunaga K., and Uchiyama T. APOBEC3G targets specific virus species. J. Virol. 78 15 (2004) 8238-8244
24. Lander J.K., Chesebro B., and Fan H. Appearance of mink cell focus-inducing recombinants during in vivo infection by Moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis. J. Virol. 73 7 (1999) 5671-5680
25. Lee Y.N., Malim M.H., and Bieniasz P.D. Hypermutation of an ancient human retrovirus by APOBEC3G. J. Virol. 82 17 (2008) 8762-8770
26. Li Q.X., and Fan H. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice. J. Virol. 64 8 (1990) 3701-3711
27. Liddament M.T., Brown W.L., Schumacher A.J., and Harris R.S. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14 15 (2004) 1385-1391
28. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 1 (1999) 77-92
29. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., and Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 6944 (2003) 99-103
30. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., and Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114 1 (2003) 21-31
31. Muckenfuss H., Hamdorf M., Held U., Perkovic M., Lower J., Cichutek K., Flory E., Schumann G.G., and Munk C. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 281 31 (2006) 22161-22172
32. Mueller-Lantzsch N., and Fan H. Monospecific immunoprecipitation of murine leukemia virus polyribosomes: identification of p30 protein-specific messenger RNA. Cell 9 4 Pt 1 (1976) 579-588
33. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 5 (2000) 553-563
34. OhAinle M., Kerns J.A., Malik H.S., and Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J. Virol. 80 8 (2006) 3853-3862
35. Okeoma C.M., Lovsin N., Peterlin B.M., and Ross S.R. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445 7130 (2007) 927-930
36. Okeoma, C.M., Low, A., Bailis, W., Hultine, S., Fan, H.Y., Peterlin, B.M., Ross, S.R., submitted for publication. APOBEC3 in viral particles and in target cells cooperatively restricts mouse mammary tumor virus infection in vivo.
37. Pion M., Granelli-Piperno A., Mangeat B., Stalder R., Correa R., Steinman R.M., and Piguet V. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 203 13 (2006) 2887-2893
38. Rose K.M., Marin M., Kozak S.L., and Kabat D. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G. AIDS Res. Hum. Retrovir. 21 7 (2005) 611-619
39. Rulli Jr. S.J., Mirro J., Hill S.A., Lloyd P., Gorelick R.J., Coffin J.M., Derse D., and Rein A. Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J. Virol. 82 13 (2008) 6566-6575
40. Santiago M.L., Montano M., Benitez R., Messer R.J., Yonemoto W., Chesebro B., Hasenkrug K.J., and Greene W.C. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321 5894 (2008) 1343-1346
41. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 6898 (2002) 646-650
42. Stenglein M.D., and Harris R.S. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem. 281 25 (2006) 16837-16841
43. Suspene R., Guetard D., Henry M., Sommer P., Wain-Hobson S., and Vartanian J.P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 102 23 (2005) 8321-8326
44. Takeda E., Tsuji-Kawahara S., Sakamoto M., Langlois M.A., Neuberger M.S., Rada C., and Miyazawa M. Mouse APOBEC3 restricts Friend leukemia virus infection and pathogenesis in vivo. J Virol. 82 (2008) 10998-11008
45. Teng B., Burant C.F., and Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260 5115 (1993) 1816-1819
46. Turelli P., Mangeat B., Jost S., Vianin S., and Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303 5665 (2004) 1829
47. Wiegand H.L., Doehle B.P., Bogerd H.P., and Cullen B.R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23 12 (2004) 2451-2458
48. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 6944 (2003) 94-98
49. Zhang L., Li X., Ma J., Yu L., Jiang J., and Cen S. The incorporation of APOBEC3 proteins into murine leukemia viruses. Virology 378 1 (2008) 69-78
50. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., and Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78 11 (2004) 6073-6076